Latest filing published 17 Aug 2026 for 4D Molecular Therapeutics, Inc., €69k.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Scott Bizily: trading record in brief
Scott Bizily appears in our data through filings on 4D Molecular Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 23 June 2026 to 17 August 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The record was last updated on 17 August 2026 with a transaction (€69k) in 4D Molecular Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Scott Bizily
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,540 shares@ US$12.19COMMONSEC144:0001950047-26-008269
- 1,635 shares@ US$11.870.0032% mcap9.3% of flowCOMMONSEC144:0001950047-26-008088
- 6,566 shares@ US$12.880.013% mcap100.0% of flowCOMMONSEC144:0001950047-26-006669
- 9,810 shares@ US$10.420.016% mcap54.8% of flowCOMMONSEC144:0001950047-26-006432
4 of 4 declarations
